These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10675504)

  • 1. Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells.
    Sachetelli S; Khalil H; Chen T; Beaulac C; Sénéchal S; Lagacé J
    Biochim Biophys Acta; 2000 Feb; 1463(2):254-66. PubMed ID: 10675504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosolization of low phase transition temperature liposomal tobramycin as a dry powder in an animal model of chronic pulmonary infection caused by Pseudomonas aeruginosa.
    Beaulac C; Sachetelli S; Lagacé J
    J Drug Target; 1999; 7(1):33-41. PubMed ID: 10614813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion between fluid liposomes and intact bacteria: study of driving parameters and in vitro bactericidal efficacy.
    Wang Z; Ma Y; Khalil H; Wang R; Lu T; Zhao W; Zhang Y; Chen J; Chen T
    Int J Nanomedicine; 2016; 11():4025-36. PubMed ID: 27574430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium.
    Ma Y; Wang Z; Zhao W; Lu T; Wang R; Mei Q; Chen T
    Int J Nanomedicine; 2013; 8():2351-60. PubMed ID: 23847417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection.
    Beaulac C; Clément-Major S; Hawari J; Lagacé J
    Antimicrob Agents Chemother; 1996 Mar; 40(3):665-9. PubMed ID: 8851590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the pulmonary and systemic immunogenicity of Fluidosomes, a fluid liposomal-tobramycin formulation for the treatment of chronic infections in lungs.
    Sachetelli S; Beaulac C; Riffon R; Lagacé J
    Biochim Biophys Acta; 1999 Aug; 1428(2-3):334-40. PubMed ID: 10434052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria.
    Beaulac C; Sachetelli S; Lagace J
    J Antimicrob Chemother; 1998 Jan; 41(1):35-41. PubMed ID: 9511035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats.
    Marier JF; Brazier JL; Lavigne J; Ducharme MP
    J Antimicrob Chemother; 2003 Aug; 52(2):247-52. PubMed ID: 12837733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the bactericidal action of amikacin, netilmicin and tobramycin in free and liposomal formulation against Pseudomonas aeruginosa.
    Omri A; Ravaoarinoro M
    Chemotherapy; 1996; 42(3):170-6. PubMed ID: 8983883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.
    Mugabe C; Halwani M; Azghani AO; Lafrenie RM; Omri A
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2016-22. PubMed ID: 16723560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin.
    Halwani M; Blomme S; Suntres ZE; Alipour M; Azghani AO; Kumar A; Omri A
    Int J Pharm; 2008 Jun; 358(1-2):278-84. PubMed ID: 18448284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa.
    Alipour M; Dorval C; Suntres ZE; Omri A
    J Pharm Pharmacol; 2011 Aug; 63(8):999-1007. PubMed ID: 21718282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
    Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A
    Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, properties and the effects of free and liposomal tobramycin on siderophore production by Pseudomonas aeruginosa.
    Poyner EA; Alpar HO; Brown MR
    J Antimicrob Chemother; 1994 Jul; 34(1):43-52. PubMed ID: 7961214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa.
    Omri A; Ravaoarinoro M; Poisson M
    J Antimicrob Chemother; 1995 Oct; 36(4):631-9. PubMed ID: 8591937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms.
    Nagant C; Tré-Hardy M; El-Ouaaliti M; Savage P; Devleeschouwer M; Dehaye JP
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):251-63. PubMed ID: 20625718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains.
    Drulis-Kawa Z; Gubernator J; Dorotkiewicz-Jach A; Doroszkiewicz W; Kozubek A
    Int J Pharm; 2006 Jun; 315(1-2):59-66. PubMed ID: 16551496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes.
    Alipour M; Suntres ZE; Lafrenie RM; Omri A
    J Antimicrob Chemother; 2010 Apr; 65(4):684-93. PubMed ID: 20159770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome encapsulation: a method for enhancing the effectiveness of local antibiotics.
    Price CI; Horton JW; Baxter CR
    Surgery; 1994 Apr; 115(4):480-7. PubMed ID: 8165539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa.
    Nichols WW; Evans MJ; Slack MP; Walmsley HL
    J Gen Microbiol; 1989 May; 135(5):1291-303. PubMed ID: 2516117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.